This press release is non-material and unlikely to move the stock. Monitor upcoming quarterly earnings for financial performance and any changes in customer acquisition or retention metrics.
Price Chart
Executive Summary
Medifast issued a press release promoting OPTAVIA's clinical evidence for visceral fat reduction and lean mass preservation, citing 18 randomized controlled trials and a 14% visceral fat reduction with 98% lean mass retention over 16 weeks. The release is a marketing/educational piece with no financial data, guidance, or material corporate events.
Key Facts
- Press release highlights OPTAVIA's clinical data: 14% visceral fat reduction and 98% lean mass retention over 16 weeks.
- No financial results, guidance, or material corporate events disclosed.
- Company cites 18 randomized controlled trials and 30+ scientific studies supporting its program.
- No new product launches, regulatory approvals, or partnership announcements.
Financial Impact
No financial impact — press release is educational/marketing content without financial data.
Risk Factors
- No financial data provided — unable to assess business performance from this release.
- Press release may be viewed as a marketing effort with no new catalysts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296058 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $11.56 | awaiting T+5 | — | $12.11 (+4.76%) |
Oct 15, 2026 11d ago | Press Release | $12.06 $12.17 | ▲ +0.91% | ▲ +1.93% | $12.11 (+0.41%) |
Oct 6, 2026 20d ago | Press Release | $11.51 $11.67 | ▲ +1.39% | ▲ +1.53% | $12.11 (+5.21%) |
Oct 1, 2026 25d ago | Press Release | $11.43 $11.43 | · 0.00% | ▼ −1.30% | $12.11 (+5.95%) |
Aug 28, 2026 8w ago | Insider Buy | $12.18 $12.63 | ▲ +3.69% | ▲ +3.59% | $12.11 (−0.57%) |
Aug 26, 2026 8w ago | Insider Buy | $12.22 $12.67 | ▲ +3.68% | ▲ +3.80% | $12.11 (−0.90%) |
Aug 21, 2026 9w ago | Insider Buy | $11.95 $12.18 | ▲ +1.92% | ▲ +1.45% | $12.11 (+1.34%) |
Jul 17, 2026 14w ago | 8-K | $10.26 $9.45 | ▼ −7.89% | ▼ −7.21% | $12.11 (+18.03%) |
Jun 1, 2026 21w ago | 8-K | $12.70 $12.10 | ▼ −4.72% | ▼ −1.97% | $12.11 (−4.65%) |
May 26, 2026 21w ago | 8-K | $12.72 $12.36 | ▼ −2.83% | ▼ −4.04% | $12.11 (−4.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers